GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) » Definitions » Inventory Turnover

Cabio Biotech (Wuhan) Co (SHSE:688089) Inventory Turnover : 0.56 (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Cabio Biotech (Wuhan) Co Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Cabio Biotech (Wuhan) Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ¥79.9 Mil. Cabio Biotech (Wuhan) Co's Average Total Inventories for the quarter that ended in Mar. 2025 was ¥141.9 Mil. Cabio Biotech (Wuhan) Co's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.56.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cabio Biotech (Wuhan) Co's Days Inventory for the three months ended in Mar. 2025 was 162.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cabio Biotech (Wuhan) Co's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.91.


Cabio Biotech (Wuhan) Co Inventory Turnover Historical Data

The historical data trend for Cabio Biotech (Wuhan) Co's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cabio Biotech (Wuhan) Co Inventory Turnover Chart

Cabio Biotech (Wuhan) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.22 2.50 3.21 2.63 2.49

Cabio Biotech (Wuhan) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.76 0.69 0.59 0.56

Cabio Biotech (Wuhan) Co Inventory Turnover Calculation

Cabio Biotech (Wuhan) Co's Inventory Turnover for the fiscal year that ended in Dec. 2024 is calculated as

Inventory Turnover (A: Dec. 2024 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2024 ) / ((Total Inventories (A: Dec. 2023 ) + Total Inventories (A: Dec. 2024 )) / count )
=313.275 / ((112.578 + 139.322) / 2 )
=313.275 / 125.95
=2.49

Cabio Biotech (Wuhan) Co's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover (Q: Mar. 2025 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Mar. 2025 ) / ((Total Inventories (Q: Dec. 2024 ) + Total Inventories (Q: Mar. 2025 )) / count )
=79.923 / ((139.322 + 144.517) / 2 )
=79.923 / 141.9195
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cabio Biotech (Wuhan) Co  (SHSE:688089) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cabio Biotech (Wuhan) Co's Days Inventory for the three months ended in Mar. 2025 is calculated as:

Days Inventory =Average Total Inventories (Q: Mar. 2025 )/Cost of Goods Sold (Q: Mar. 2025 )*Days in Period
=141.9195/79.923*365 / 4
=162.03

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cabio Biotech (Wuhan) Co's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=141.9195 / 155.966
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Cabio Biotech (Wuhan) Co Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Cabio Biotech (Wuhan) Co's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Cabio Biotech (Wuhan) Co Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Gaoxin Avenue, East Lake New Technology Development Zone, Hubei Province, Wuhan, CHN, 430075
Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.
Executives
Shang Yun Core technical personnel
Xiao Min senior management
Wang Hua Biao Directors, senior managers
Geng An Feng senior management
Du Bin Director
Yi Hua Rong senior management
Ma Tao senior management
Li Xiang Yu senior management
Wu Yu Jun Supervisors
Wang Zhi Ming senior management
Lu Shu Huan Core technical personnel
Yi De Wei Director

Cabio Biotech (Wuhan) Co Headlines

No Headlines